Researchers developed a new method to build bacteriophage DNA. They modelled synthetic DNA after two natural phages that attack Mycobacterium, a group that includes the bacteria that cause tuberculosis and leprosy. The team edited these synthetic genomes and published the results in the Proceedings of the National Academy of Sciences.
Some phage genomes are hard to build because they have many G and C bases. DNA has four base letters, A, T, C and G. The team built each genome in sections and put the sections into a cell. The cell read the new genome and produced phages. Synthetic genomes could make finding matching phages faster and reduce the need to store many samples.
Difficult words
- bacteriophage — a virus that infects and kills bacteria
- synthetic — made by people, not by nature
- genome — all the genetic information in an organismgenomes
- phage — a virus that attacks bacteriaphages
- base — the letters that make up DNAbases
- edit — changed DNA letters or partsedited
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- How could synthetic genomes help scientists in their work?
- Would you want to study genomes or viruses? Why or why not?
- Do you think making phages in a cell is better than storing many samples? Why?
Related articles
AI coach helps medical students learn suturing
Researchers at Johns Hopkins developed an explainable AI tool that gives immediate text feedback to medical students practicing suturing. A small randomized study found faster learning for students with prior experience; beginners showed less benefit.
Psychedelics change blood-flow signals in brain imaging
Researchers at Washington University found that psychedelics acting on serotonin can disrupt the normal link between neuronal activity and blood flow in mice. Similar effects appeared with psilocybin and in reanalyzed human fMRI data.
Antibody and EGFR–STAT1 pathway point to new fibrosis treatments
Researchers at Yale found a human antibody that blocks epiregulin and lowers fibrosis markers. They also show EGFR activates STAT1 in fibroblasts, suggesting two treatment paths: block epiregulin or target the EGFR–STAT1 pathway.
Biodegradable patch may help heart heal after heart attack
Researchers report a biodegradable microneedle patch that delivers interleukin-4 to injured heart tissue. The local treatment encourages healing immune cells, reduces scarring, and may improve heart recovery while avoiding systemic side effects.
